AstraZeneca PLC (AZN) — Strategic Asset Allocation Index
AstraZeneca PLC (AZN) has a Strategic Asset Allocation Index of 30.2% as of December 2025. Strategic assets (PP&E of $14.70 Billion plus long-term investments of $-) total $14.70 Billion, measured against net assets of $48.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of AstraZeneca PLC to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
AstraZeneca PLC Strategic Asset Allocation Index (2022–2025)
This chart shows how AstraZeneca PLC's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 30.2%, representing strategic assets of $14.70 Billion against net assets of $48.72 Billion USD. For live market cap and overall valuation, see AstraZeneca PLC market cap and net worth.
Annual Strategic Asset Allocation Index for AstraZeneca PLC (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for AstraZeneca PLC from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See AstraZeneca PLC (AZN) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 30.2% | $14.70 Billion | $14.70 Billion | $- | $48.72 Billion | ▲ +1.7 pp |
| 2024 | 28.5% | $11.65 Billion | $11.65 Billion | $- | $40.87 Billion | ▲ +1.7 pp |
| 2023 | 26.8% | $10.50 Billion | $10.50 Billion | $- | $39.17 Billion | ▲ +1.3 pp |
| 2022 | 25.5% | $9.45 Billion | $9.45 Billion | $- | $37.06 Billion | — |